Higher Risk for CRC Seen in Adults Exposed to Bendectin In Utero
TUESDAY, March 28, 2023 (HealthDay News) — Adults exposed in utero to the antiemetic Bendectin (doxylamine/pyridoxine/dicyclomine), prescribed during pregnancy in the 1960s, have an increased risk for colorectal cancer (CRC), according to a study pub…
Learn MoreHydroxyurea Underused in Youth With Sickle Cell
TUESDAY, March 28, 2023 (HealthDay News) — Few youths with sickle cell anemia (SCA) receive hydroxyurea despite national guidelines recommending its use, according to a study published online March 24 in JAMA Network Open.Sarah L. Reeves, Ph.D., from…
Learn MoreAAD: Long-Term Improvement Seen With Ruxolitinib in Vitiligo
TUESDAY, March 28, 2023 (HealthDay News) — For patients with nonsegmental vitiligo, continued improvement was seen during a long-term extension of ruxolitinib treatment, according to a study presented at the annual meeting of the American Academy of …
Learn MoreComparative Effectiveness of Meds for Acute Low Back Pain Unclear
MONDAY, March 27, 2023 (HealthDay News) — For patients with acute low back pain, the comparative effectiveness and safety of analgesic medications is unclear, according to a systematic review and meta-analysis published online March 22 in The BMJ.Mic…
Learn MoreNirmatrelvir Cuts Risk for Post-COVID-19 Condition
MONDAY, March 27, 2023 (HealthDay News) — Treatment with nirmatrelvir during the acute phase of COVID-19 may reduce the risk for postacute adverse health outcomes, according to a study published online March 23 in JAMA Internal Medicine.Yan Xie, Ph.D…
Learn MoreThe Most Common Anxiety Medications, Explained
FRIDAY, March 24, 2023 (HealthDay News) — Endless worry, irritability and insomnia are all symptoms of a possible anxiety disorder.Luckily, there are numerous anxiety medications that can help ease the condition.Joy Alonzo, a specialist in the pharma…
Learn MoreDrug Shortages Rose by 30 Percent in 2022, U.S. Senate Report Shows
THURSDAY, March 23, 2023 (HealthDay News) — Americans are facing shortages of drugs critical for cancer treatment, respiratory conditions, and more — shortages that increased nearly 30 percent between 2021 and 2022, a new report shows. The report, c…
Learn MorePrenatal Exposure to Phentermine-Topiramate Lower Under Safety Program
TUESDAY, March 21, 2023 (HealthDay News) — Under the Risk Evaluation and Mitigation Strategy (REMS), prenatal exposure to phentermine-topiramate is lower than topiramate and other antiobesity medications (AOMs), according to a study published online …
Learn MoreEmpagliflozin Improves HbA1c in Young People With T2DM
TUESDAY, March 21, 2023 (HealthDay News) — For young people, empagliflozin is associated with improvement in glycated hemoglobin (HbA1c), according to a study published in the March issue of The Lancet Diabetes & Endocrinology.Lori M. Laffel, M.D., f…
Learn MoreWeight Gain, Raised BP Risk Seen for HIV Patients Switching to Dolutegravir
TUESDAY, March 21, 2023 (HealthDay News) — For Black patients with HIV on antiretroviral therapy (ART), those who switch from efavirenz to dolutegravir gain more weight and have an increased risk for hypertension, according to a study published in th…
Learn More